The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4430569 4189219 F 1 4430569-2 20040624 20040809 20040818 EXP 2004-07-1271 SCHERING-PLOUGH CORPORATION 43 YR M N 20040812 MD

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4430569 1005132461 PS PEG-INTRON 1 SUBCUTANEOUS 120 MCG QWK SUBCUTANEOUS U D
4430569 1005146797 SS REBETOL 1 ORAL ORAL U D

Indications of drugs used

Event ID DRUG SEQ INDI PT
4430569 1005132461 HEPATITIS C
4430569 1005146797 HEPATITIS C

Outcome of event

Event ID OUTC COD
4430569 HO
4430569 OT

Reactions reported

Event ID PT
4430569 DISEASE RECURRENCE
4430569 PULMONARY EMBOLISM

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4430569 FGN
4430569 HP
4430569 OTH

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4430569 1005132461 20040101 20040722